OW raises £2.2m in a pre-series A round led by Parkwalk Advisors to advance digital scent technology
Parkwalk Advisors led the raise alongside a grant from Innovate UK to support the development of sleep technology applications.
OW combines artificial intelligence and proprietary hardware to digitise and print smells for various applications. Its initial focus is on improving human sleep quality through personalised scent delivery.
OW has secured £2.2m in a pre-series A funding round led by Parkwalk Advisors, which contributed £1.5m alongside a £700k grant from Innovate UK. The spinout combines artificial intelligence with innovative hardware to digitise smell, with an initial focus on enhancing sleep quality. The capital will enable the firm to undertake extensive validation studies for sleep interventions, train its AI algorithms using biofeedback, and expand its intellectual property portfolio.
From the founder
"Smell can be our most powerful sense and only now are we realising the potential of technology to translate it for experience, welfare and health. This technology has enormous commercial applications which this new investment will help us unlock."
Emanuela Maggioni
CEO, CTO & Co-Founder at OW
Investor perspective
"OW is a fantastic example of the cutting-edge technology created in UK universities. OW is helping to bring the experience of smell in line with major advances in both video and sound. Digitalising smell and delivering personalised scents into homes is a major step forward in immersive experiences and has vast potential."
John Pearson
Chief Investment Officer, Parkwalk Advisors
Use of funds
- 01Fund research and development
